- Cerebras Systems is offering 28 million shares at $115–$125 each, targeting up to $3.5 billion in proceeds in a Nasdaq listing under the ticker CBRS, led by Morgan Stanley, Citi, Barclays, and UBS.
- Banks have already received over $10 billion in indications of interest — roughly 3x oversubscribed at the high end of the range.
- OpenAI signed a $20 billion multi-year deal with Cerebras in January and has lent the company $1 billion in working capital; Amazon committed to using Cerebras chips alongside its Trainium processors.
- U.S. IPO proceeds stand at $17.6 billion year-to-date — nearly double the same period last year — ahead of what could be the largest listing ever if SpaceX pursues its targeted $75 billion raise.
What Happened?
Cerebras Systems, the Sunnyvale-based AI chipmaker and data center operator, formally filed its IPO pricing range with the SEC: 28 million shares at $115 to $125 each, for gross proceeds of up to $3.5 billion. The offering is led by Morgan Stanley, Citigroup, Barclays, and UBS, with shares set to trade on Nasdaq under the symbol CBRS. The company previously filed confidentially earlier this year after withdrawing an earlier registration. Banks have already lined up more than $10 billion in potential orders — a level of demand that signals strong institutional appetite heading into the roadshow.
Why It Matters?
Cerebras is positioning itself as the most credible challenger to Nvidia’s dominance in AI accelerator chips. Its core product — an unusually large wafer-scale chip — processes data in ways the company says outpace Nvidia’s GPUs for certain AI workloads. The customer roster validates the thesis: OpenAI, which signed a $20 billion multi-year deal and extended $1 billion in working capital, is a marquee endorsement. Amazon’s commitment to use Cerebras chips alongside its own Trainium processors marks the first major hyperscaler to deploy the company’s hardware. If the IPO prices at the top of the range, the listing will further signal that the public markets are open and receptive to AI infrastructure plays ahead of SpaceX’s potentially record-breaking debut.
What’s Next?
Watch for the final pricing and first-day trading performance as a read on institutional risk appetite for AI pure-plays at premium valuations. Cerebras will need to demonstrate that its revenue and customer pipeline can justify the price, particularly given that Nvidia continues to dominate at scale. The broader IPO market context matters too — if SpaceX proceeds with its $75 billion listing later this year, Cerebras’s performance will be an important data point for how investors calibrate AI hardware valuations heading into that deal.
Source: Bloomberg
